ArsenalBio is a startup based in the United States, 1 tracked investor.
ArsenalBio is a startup founded in 2020 based in the United States. Brouky records 1 investor associated with the company.
ArsenalBio develops cell programming technology to engineer custom cellular therapies for treating cancer and other diseases by reprogramming cells with synthetic biology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.